0002057800-25-000001.txt : 20250224 0002057800-25-000001.hdr.sgml : 20250224 20250224163446 ACCESSION NUMBER: 0002057800-25-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20250224 DATE AS OF CHANGE: 20250224 EFFECTIVENESS DATE: 20250224 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Newleos Therapeutics, Inc. CENTRAL INDEX KEY: 0002057800 ORGANIZATION NAME: IRS NUMBER: 994922199 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-539081 FILM NUMBER: 25657605 BUSINESS ADDRESS: STREET 1: C/O NEWLEOS THERAPEUTICS, INC. STREET 2: 800 BOYLSTON STREET, SUITE 1715 CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: (617) 648-9100 MAIL ADDRESS: STREET 1: C/O NEWLEOS THERAPEUTICS, INC. STREET 2: 800 BOYLSTON STREET, SUITE 1715 CITY: BOSTON STATE: MA ZIP: 02199 D 1 primary_doc.xml X0708 D LIVE 0002057800 Newleos Therapeutics, Inc. C/O NEWLEOS THERAPEUTICS, INC. 800 BOYLSTON STREET, SUITE 1715 BOSTON MA MASSACHUSETTS 02199 (617) 648-9100 DELAWARE None None Corporation true 2024 David Donabedian c/o Newleos Therapeutics, Inc. 800 Boylston Street, Suite 1715 Boston MA MASSACHUSETTS 02199 Executive Officer Director John McCabe c/o Newleos Therapeutics, Inc. 800 Boylston Street, Suite 1715 Boston MA MASSACHUSETTS 02199 Executive Officer Ming Cheah c/o Newleos Therapeutics, Inc. 800 Boylston Street, Suite 1715 Boston MA MASSACHUSETTS 02199 Director Christoph Westphal c/o Newleos Therapeutics, Inc. 800 Boylston Street, Suite 1715 Boston MA MASSACHUSETTS 02199 Director Raymond Camahort c/o Newleos Therapeutics, Inc. 800 Boylston Street, Suite 1715 Boston MA MASSACHUSETTS 02199 Director Robert Hadfield c/o Newleos Therapeutics, Inc. 800 Boylston Street, Suite 1715 Boston MA MASSACHUSETTS 02199 Executive Officer Biotechnology Decline to Disclose 06b false 2025-02-10 false true false 0 93449993 93449993 0 false 11 0 0 0 false Newleos Therapeutics, Inc. /s/ David Donabedian David Donabedian President and CEO 2025-02-24